Department of Innovative Research & Education for Clinicians & Trainees (DiRECT)

英文原著 2017年度実績

  1. Omae K, Tsujimoto Y, Honda M, Kondo T, Tanabe K, Fukuhara S, Furukawa T.
    Comparative Efficacy and Safety of Bone-modifying Agents for the Treatment of Bone Metastases in Patients with Advanced Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
    Oncotarget (in press).
  2. Yokoyama K*, Kurita N*, Fukuma S, Akizawa T, Fukagawa M, Onishi Y, Kurokawa K, Fukuhara S. (*co-first authors)
    Frequent monitoring of mineral metabolism in hemodialysis patients with secondary hyperparathyroidism: associations with achievement of treatment goals and with adjustments in therapy.
    Nephrology Dialysis Transplantation 2017; 32: 534-541.
  3. Omae K, Fukuma S, Ikenoue T, Kondo T, Takagi T, Ishihara H, Tanabe K, Fukuhara S
    Impact of ABO blood type on the outcomes of metastatic renal cell carcinoma patients treated with first-line tyrosine kinase inhibitors.
    Urologic Oncology (in press).
  4. Haga N, Kurita N, Yanagida T, Ogawa S, Yabe M, Akaihata H, Hata J, Sato Y, Ishibashi K, Hasegawa O, Kojima Y.
    Effects of Barbed Suture during Robot-assisted Radical Prostatectomy on Postoperative Tissue Damage and Longitudinal Changes in Lower Urinary Tract Outcome.
    Surgical Endoscopy (in press)
  5. Kurita N, Hayashino Y, Yamazaki S, Akizawa T, Akiba T, Saito A, Fukuhara S.
    Revisiting Interdialytic Weight Gain and Mortality Association With Serum Albumin Interactions: The Japanese Dialysis Outcomes and Practice Pattern Study.
    Journal of Renal Nutrition 2017; 27: 421-429.
  6. Niihata K, Takahashi S, Kurita N, Yajima N, Omae K, Fukuma S, Okano T, Nomoto Y, Omori K, Fukuhara S.
    Association between accumulation of advanced glycation end-products and hearing impairment in community-dwelling older people: a cross-sectional Sukagawa study.
    Journal of the American Medical Directors Association (in press)
  7. Inoue H, Shimizu S, Watanabe K, Kamiyama Y, Shima H, Nakase A, Ishida H, Kurita N, Fukuma S, Fukuhara S, Yamada Y.
    Impact of of trajectories of abdominal aortic calcification over 2 years on subsequent mortality: a 10-year longitudinal study.
    Nephrology Dialysis Transplantation (in press)
  8. Miyamoto M, Kurita N, Suemitsu K, Murakami M.
    Fistula and survival outcomes after fistula creation among predialysis chronic kidney disease stage 5 patients.
    American Journal of Nephrology 2017; 45: 356-364.
  9. Kamitani T, Yamamoto Y, Kurita N, Yamazaki S, Fukuma S, Otani K, Sekiguchi M, Onishi Y, Takegami M, Ono R, Konno S, Kikuchi S, Fukuhara S.
    Longitudinal association between subjective fatigue and future falls in community-dwelling older adults: the Locomotive Syndrome and Health Outcomes in the Aizu Cohort Study (LOHAS)
    Journal of Aging and Health (in press)
  10. Omae K, Kondo T, Takagi T, Iizuka J, Hashimoto Y, Kobayashi H, Tanabe K.
    Surgical and Oncologic Outcomes of Laparoscopic Radical Nephrectomy for Non-metastatic Renal Cancer in Long-term Dialysis Patients.
    Ther Apher Dial. 2017; 21: 31-37.
  11. Kataoka Y, Yamamoto S, Omae K, Kokubo M, Goto Y, Takada T, Naganuma T, Nishiwaki H, Yajima N.
    A novel approach of understanding prediction models: TRIPOD framework.
    Journal of General and Family Medicine (in press).
  12. Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K.
    Evaluation of preoperative aspartate transaminase/alanine transaminase ratio as an independent predictive biomarker in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy: A propensity score matching study.
    Clinical Genitourinary Cancer 2017(in press).
  13. Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K.
    Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy.
    Urologic Oncology 2017; 35: 539.e9-16.
  14. Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K.
    Time to progression after first-line tyrosine kinase inhibitor predicts survival in patients with metastatic renal cell carcinoma receiving second-line molecular-targeted therapy.
    Urologic Oncology 2017; 35: 542.e1-9.